Treatment com AI (XCNQ:TRUE) 3-Year EBITDA Growth Rate : 17.60% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Treatment com AI 3-Year EBITDA Growth Rate?

Treatment com AI's EBITDA per Share for the three months ended in Dec. 2023 was C$-0.14.

During the past 3 years, the average EBITDA Per Share Growth Rate was 17.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of Treatment com AI was 17.60% per year. The lowest was -79.20% per year. And the median was -30.80% per year.

Competitive Comparison of Treatment com AI's 3-Year EBITDA Growth Rate

For the Health Information Services subindustry, Treatment com AI's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Treatment com AI's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Treatment com AI's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Treatment com AI's 3-Year EBITDA Growth Rate falls into.

Treatment com AI 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Treatment com AI (XCNQ:TRUE) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Treatment com AI 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Treatment com AI's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Treatment com AI (XCNQ:TRUE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Treatment com AI Inc (XCNQ:TRUE) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

TREIF:USA 939:Germany

Address

838 West Hastings Street, Suite 700, Vancouver, BC, CAN, V6C 0A6

Website

https://www.treatment.com

Treatment com AI Inc operates in the business of providing personalized health care information that is relevant and trustworthy empowering patients to make responsible, informed decisions about their health while improving communications, reducing costs and in-clinic wait times for medical practitioners.

Executives

Essam Hamza

Director, Senior Officer